AAV2.5T Serotype
Chimeric serotype combining AAV2 and AAV5 capsid sequences for enhanced muscle transduction with improved tissue distribution.
Characteristics
Hybrid capsid structure combining AAV2 and AAV5 sequences. Enhanced muscle transduction efficiency versus parental serotypes. Improved intramuscular spread. Reduced immunogenicity profile.
Applications
Duchenne muscular dystrophy gene therapy. Limb-girdle muscular dystrophies. Cardiac gene therapy applications.
Literature References
- Bowles et al. (2012). Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther - Bowles 2012 AAV2.5T
Related collections
-
AAV Vectors
Adeno-associated viral vectors for in vivo and ex vivo gene delivery. From...
-
CRISPR Tools
Comprehensive CRISPR components for custom genome editing workflows. Guide RNAs, nuclease variants,...
-
Base Editing
Precision single-nucleotide conversion without double-strand breaks. Adenine base editors (A→G), cytosine base...
-
Prime Editing
Search-and-replace genome editing without double-strand breaks or donor templates. Prime editors enable...
